Valentina Garrapa

Valentina is the CEO of preclinics Italia.

Valentina is a molecular biologist with a Ph.D. in Biotechnology. Her background is highly focused on VHHs, the variable domain of Camelid’s heavy chain antibodies. During the years she affined his knowledge in VHH expression, selection, and manipulation. After working for two years for preclinics GmbH, she founded preclinics Italia, an innovative start-up specialized in VHHs.